GPX4 and neoplasm: To further elucidate the mechanism by which C820 NPs enhance CDDP sensitivity in vivo, immunohistochemistry and immunofluorescence staining of GPX4 and HIF-1 expression in LoVo/CDDP tumor tissues was performed (Fig. 6G).